These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6674545)

  • 21. [Clinical studies on cefoxitin in the field of obstetrics and gynecology].
    Cho N; Suzuki H; Itagaki T; Hirai N; Seki M; Kondo H; Nishimoto S; Togo M; Simizu S; Ozaki T
    Jpn J Antibiot; 1985 Feb; 38(2):212-22. PubMed ID: 4009945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].
    Kałowski M; Dybicki J; Kedzia A; Lukiański M
    Wiad Lek; 1993 Mar; 46(5-6):211-5. PubMed ID: 8249400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients].
    Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K
    Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of cefroxadine in the field of obstetrics and gynecology].
    Okada N; Sugimoto Y; Suno N; Shikato Y
    Jpn J Antibiot; 1983 Sep; 36(9):2556-61. PubMed ID: 6655870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies of cefotaxime (CTX, HR 756) for infectious diseases in the field of obstetrics and gynecology (author's transl)].
    Hayasaki M; Iwasa S; Noda K; Itoh K
    Jpn J Antibiot; 1981 Apr; 34(4):489-94. PubMed ID: 6270396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Satranidazole: experimental evaluation of activity against anaerobic bacteria in vitro and in animal models of anaerobic infection.
    Gowrishankar R; Phadke RP; Oza SD; Talwalker S
    J Antimicrob Chemother; 1985 Apr; 15(4):463-70. PubMed ID: 4008378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the clinical effect of ceftazidime in the field of obstetrics and gynecology].
    Chimura T; Gotou T; Matsuo M; Koseki K; Aoyama S
    Jpn J Antibiot; 1983 Dec; 36(12):3483-90. PubMed ID: 6371296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
    Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
    Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of microbial trigger based oral formulation of Tinidazole and its Gamma Scintigraphy Evaluation: A promising tool against anaerobic microbes associated GI problems.
    Sharma BG; Kumar N; Nishad DK; Khare NK; Bhatnagar A
    Eur J Pharm Sci; 2016 Jun; 89():94-104. PubMed ID: 27108116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basic and clinical studies on cefotiam in the field of obstetrics and gynecology].
    Ninomiya K; Ohbayashi F; Hasegawa Y; Hamaya K; Nishio T
    Jpn J Antibiot; 1982 Dec; 35(12):2812-21. PubMed ID: 6304363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 12 year study of aerobic and anaerobic bacteria in intra-abdominal and postsurgical abdominal wound infections.
    Brook I
    Surg Gynecol Obstet; 1989 Nov; 169(5):387-92. PubMed ID: 2683149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro susceptibilities of BRL 25000 (clavulanic acid-amoxicillin) against causative organisms in the field of obstetrics and gynecology].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Yoshihara H; Oda S; Matsumoto Y; Ikegami R; Sato K
    Jpn J Antibiot; 1986 Mar; 39(3):842-52. PubMed ID: 3488425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
    Werner H; Kuchenbecker K; Hammann R
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerobic and anaerobic microbiologic factors and recovery of beta-lactamase producing bacteria from obstetric and gynecologic infection.
    Brook I; Frazier EH; Thomas RL
    Surg Gynecol Obstet; 1991 Feb; 172(2):138-44. PubMed ID: 1989117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1985 Apr; 38(4):926-39. PubMed ID: 4032730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Tateno M
    Jpn J Antibiot; 1985 Apr; 38(4):982-6. PubMed ID: 3897615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Obata I; Hayashi F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1985 Apr; 38(4):940-53. PubMed ID: 4032731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Aug; 24(2):85-117. PubMed ID: 6749473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.